The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global COVID-19 Diagnosis Market Research Report 2025
Synopsis
The COVID-19 pandemic has been declared as a global health crisis by WHO and is one of the greatest challenges ever faced by mankind since World War II. After its emergence in Wuhan, China by the end of December 2019, the virus has spread across 184 countries through the first quarter of 2020. Incidence of the infection is observed to be increasing daily in the Americas, Europe, and Africa. Although several strains of coronavirus have been identified and studied earlier, the new disease has been caused due to a novel strain and in no time turned into a pandemic due to a high R-naught. The virus is expected to impact the socioeconomic and political landscape of the countries, consequently leading to adverse economic impact.
The global COVID-19 Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for COVID-19 Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Diagnosis.
Report Scope
The COVID-19 Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COVID-19 Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cepheid
Abbott
Mesa Biotech
Microsens Dx
GenMark Diagnostics
Credo
Quest Diagnostics
LabCorp
Roche Diagnostics
Thermo Fisher Scientific
BD
PerkinElmer
Quidel
Segment by Type
RT-PCR
Isothermal Nucleic Acid Amplification
Others
Segment by Application
Hospital
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COVID-19 Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The COVID-19 pandemic has been declared as a global health crisis by WHO and is one of the greatest challenges ever faced by mankind since World War II. After its emergence in Wuhan, China by the end of December 2019, the virus has spread across 184 countries through the first quarter of 2020. Incidence of the infection is observed to be increasing daily in the Americas, Europe, and Africa. Although several strains of coronavirus have been identified and studied earlier, the new disease has been caused due to a novel strain and in no time turned into a pandemic due to a high R-naught. The virus is expected to impact the socioeconomic and political landscape of the countries, consequently leading to adverse economic impact.
The global COVID-19 Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for COVID-19 Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Diagnosis.
Report Scope
The COVID-19 Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COVID-19 Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cepheid
Abbott
Mesa Biotech
Microsens Dx
GenMark Diagnostics
Credo
Quest Diagnostics
LabCorp
Roche Diagnostics
Thermo Fisher Scientific
BD
PerkinElmer
Quidel
Segment by Type
RT-PCR
Isothermal Nucleic Acid Amplification
Others
Segment by Application
Hospital
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COVID-19 Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 RT-PCR
1.2.3 Isothermal Nucleic Acid Amplification
1.2.4 Others
1.3 Market by Application
1.3.1 Global COVID-19 Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Diagnosis Market Perspective (2019-2030)
2.2 COVID-19 Diagnosis Growth Trends by Region
2.2.1 Global COVID-19 Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 COVID-19 Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 COVID-19 Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 COVID-19 Diagnosis Market Dynamics
2.3.1 COVID-19 Diagnosis Industry Trends
2.3.2 COVID-19 Diagnosis Market Drivers
2.3.3 COVID-19 Diagnosis Market Challenges
2.3.4 COVID-19 Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Diagnosis Players by Revenue
3.1.1 Global Top COVID-19 Diagnosis Players by Revenue (2019-2024)
3.1.2 Global COVID-19 Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global COVID-19 Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Diagnosis Revenue
3.4 Global COVID-19 Diagnosis Market Concentration Ratio
3.4.1 Global COVID-19 Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnosis Revenue in 2023
3.5 COVID-19 Diagnosis Key Players Head office and Area Served
3.6 Key Players COVID-19 Diagnosis Product Solution and Service
3.7 Date of Enter into COVID-19 Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Diagnosis Breakdown Data by Type
4.1 Global COVID-19 Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global COVID-19 Diagnosis Forecasted Market Size by Type (2025-2030)
5 COVID-19 Diagnosis Breakdown Data by Application
5.1 Global COVID-19 Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global COVID-19 Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America COVID-19 Diagnosis Market Size (2019-2030)
6.2 North America COVID-19 Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America COVID-19 Diagnosis Market Size by Country (2019-2024)
6.4 North America COVID-19 Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe COVID-19 Diagnosis Market Size (2019-2030)
7.2 Europe COVID-19 Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe COVID-19 Diagnosis Market Size by Country (2019-2024)
7.4 Europe COVID-19 Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific COVID-19 Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific COVID-19 Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific COVID-19 Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific COVID-19 Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America COVID-19 Diagnosis Market Size (2019-2030)
9.2 Latin America COVID-19 Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America COVID-19 Diagnosis Market Size by Country (2019-2024)
9.4 Latin America COVID-19 Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa COVID-19 Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa COVID-19 Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa COVID-19 Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa COVID-19 Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cepheid
11.1.1 Cepheid Company Detail
11.1.2 Cepheid Business Overview
11.1.3 Cepheid COVID-19 Diagnosis Introduction
11.1.4 Cepheid Revenue in COVID-19 Diagnosis Business (2019-2024)
11.1.5 Cepheid Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Diagnosis Introduction
11.2.4 Abbott Revenue in COVID-19 Diagnosis Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Mesa Biotech
11.3.1 Mesa Biotech Company Detail
11.3.2 Mesa Biotech Business Overview
11.3.3 Mesa Biotech COVID-19 Diagnosis Introduction
11.3.4 Mesa Biotech Revenue in COVID-19 Diagnosis Business (2019-2024)
11.3.5 Mesa Biotech Recent Development
11.4 Microsens Dx
11.4.1 Microsens Dx Company Detail
11.4.2 Microsens Dx Business Overview
11.4.3 Microsens Dx COVID-19 Diagnosis Introduction
11.4.4 Microsens Dx Revenue in COVID-19 Diagnosis Business (2019-2024)
11.4.5 Microsens Dx Recent Development
11.5 GenMark Diagnostics
11.5.1 GenMark Diagnostics Company Detail
11.5.2 GenMark Diagnostics Business Overview
11.5.3 GenMark Diagnostics COVID-19 Diagnosis Introduction
11.5.4 GenMark Diagnostics Revenue in COVID-19 Diagnosis Business (2019-2024)
11.5.5 GenMark Diagnostics Recent Development
11.6 Credo
11.6.1 Credo Company Detail
11.6.2 Credo Business Overview
11.6.3 Credo COVID-19 Diagnosis Introduction
11.6.4 Credo Revenue in COVID-19 Diagnosis Business (2019-2024)
11.6.5 Credo Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Detail
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics COVID-19 Diagnosis Introduction
11.7.4 Quest Diagnostics Revenue in COVID-19 Diagnosis Business (2019-2024)
11.7.5 Quest Diagnostics Recent Development
11.8 LabCorp
11.8.1 LabCorp Company Detail
11.8.2 LabCorp Business Overview
11.8.3 LabCorp COVID-19 Diagnosis Introduction
11.8.4 LabCorp Revenue in COVID-19 Diagnosis Business (2019-2024)
11.8.5 LabCorp Recent Development
11.9 Roche Diagnostics
11.9.1 Roche Diagnostics Company Detail
11.9.2 Roche Diagnostics Business Overview
11.9.3 Roche Diagnostics COVID-19 Diagnosis Introduction
11.9.4 Roche Diagnostics Revenue in COVID-19 Diagnosis Business (2019-2024)
11.9.5 Roche Diagnostics Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific COVID-19 Diagnosis Introduction
11.10.4 Thermo Fisher Scientific Revenue in COVID-19 Diagnosis Business (2019-2024)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 BD
11.11.1 BD Company Detail
11.11.2 BD Business Overview
11.11.3 BD COVID-19 Diagnosis Introduction
11.11.4 BD Revenue in COVID-19 Diagnosis Business (2019-2024)
11.11.5 BD Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Detail
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer COVID-19 Diagnosis Introduction
11.12.4 PerkinElmer Revenue in COVID-19 Diagnosis Business (2019-2024)
11.12.5 PerkinElmer Recent Development
11.13 Quidel
11.13.1 Quidel Company Detail
11.13.2 Quidel Business Overview
11.13.3 Quidel COVID-19 Diagnosis Introduction
11.13.4 Quidel Revenue in COVID-19 Diagnosis Business (2019-2024)
11.13.5 Quidel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
